Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...
Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online ...
Comprehensive study exposes critical health risks of obesity, including diabetes, heart disease, and cancer, while offering ...
The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market ...
Amgen Inc. sees the potential for 2025 revenues to top Wall Street estimates thanks to growth in cholesterol and cancer drugs ...
GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...
Although obese individuals are at greater risk of diabetes, high blood pressure or high cholesterol, not all obese people ...
The economic burden of obesity is also significant. In the Finger Lakes, excess medical spending due to obesity is estimated ...
19hon MSN
Emily Field, head of European pharmaceuticals research at Barclays, weighs in on rising competition in the global obesity ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback